C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer

CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis

(2019) Bhawna Sharma et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases

(2019) Yuan Cheng et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

RIP 3 deficiency recruits myeloid‐derived suppressor cells to hepatocellular carcinoma through the CXCL 1‐ CXCR 2 axis

(2019) Yi‐Ming Li et al.   HEPATOLOGY

CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor

(2019) Bin Liu et al.   Cancers

Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway

(2018) Dong Cui et al.   BIOCHIMIE

The role of STAT3 in leading the crosstalk between human cancers and the immune system

(2018) Yu Wang et al.   CANCER LETTERS

CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2

(2018) Han Xu et al.   CANCER LETTERS

Tumor-infiltrating CD45RO+ memory cells correlate with favorable prognosis in patients with lung adenocarcinoma

(2018) Zhangguo Hu et al.   Journal of Thoracic Disease

CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT‐11‐resistant LoVo colon cancer cells via Gαi‐2 and Gαq/11

(2018) Ming‐Cheng Chen et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non–Small Cell Lung Cancer

(2017) Elizabeth A. David et al.   Journal of Thoracic Oncology

Precision Diagnosis and Treatment for Advanced Non–Small-Cell Lung Cancer

(2017) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss of β-arrestin-2 and Activation of CXCR2 Correlate with Lymph Node Metastasis in Non-small Cell Lung Cancer

(2017) Lei Cong et al.   Journal of Cancer

Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma

(2017) Hiroaki Kasashima et al.   PLoS One

TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma

(2016) Kuang-Hui Sun et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma

(2015) Huimin An et al.   EUROPEAN JOURNAL OF CANCER

CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma

(2015) Li Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Depletion of  -Arrestin-2 Promotes Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer

(2014) S. K. Raghuwanshi et al.   JOURNAL OF IMMUNOLOGY

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

(2014)   LANCET

Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma

(2014) Hideaki Sueoka et al.   SURGERY

High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer

(2014) LUNQING WANG et al.   Oncology Letters

The Chemokine Superfamily Revisited

(2012) Albert Zlotnik et al.   IMMUNITY